Comparative Performance of Cell Life Span and Cell Transit Models for Describing Erythropoietic Drug Effects
Open Access
- 18 October 2011
- journal article
- research article
- Published by Springer Nature in The AAPS Journal
- Vol. 13 (4) , 650-661
Abstract
Prolonged time delay in response to drug action is a common feature of hematological responses to pharmacotherapy such as erythropoiesis. The objective of this study was to compare the performance of two competing modeling approaches for delayed drug effects, mechanistic cell life span models, and semi-mechanistic cell transit models. The comparison was performed with an experimental dataset from multiple dose administrations of an erythropoietin mimetic to Cynomolgus monkeys. Comparative performance measures include visual predictive checks, goodness-of-fit plots, model estimation time, estimation status, and estimation error. The analysis revealed that both models resulted in a similarly good description of the erythropoietic drug effect, with precision and bias of the model-based predictions of red blood cell counts of less than 11%. The cell transit model needed slightly longer time to converge compared to the cell life span model. The system and drug effect parameters were similar in both models indicating that the models can be interchangeably used to describe the current data. Thus, model selection would be dependent on the purpose of the modeling exercise, the available data, and the time allocated for model development.Keywords
This publication has 36 references indexed in Scilit:
- Interpretation of transit compartments pharmacodynamic models as lifespan based indirect response modelsJournal of Pharmacokinetics and Pharmacodynamics, 2010
- Pharmacodynamics-Mediated Drug Disposition (PDMDD) and Precursor Pool Lifespan Model for Single Dose of Romiplostim in Healthy SubjectsThe AAPS Journal, 2010
- Comparison of Two Pharmacodynamic Transduction Models for the Analysis of Tumor Therapeutic Responses in Model SystemsThe AAPS Journal, 2009
- Basic pharmacodynamic models for agents that alter the lifespan distribution of natural cellsJournal of Pharmacokinetics and Pharmacodynamics, 2008
- Development of Translational Pharmacokinetic–Pharmacodynamic ModelsClinical Pharmacology & Therapeutics, 2008
- Pharmacodynamic Analysis of Recombinant Human Erythropoietin Effect on Reticulocyte Production Rate and Age Distribution in Healthy SubjectsClinical Pharmacokinetics, 2008
- Development and evaluation of a population pharmacokinetic-pharmacodynamic model of darbepoetin alfa in patients with nonmyeloid malignancies undergoing multicycle chemotherapyThe AAPS Journal, 2006
- Metrics for External Model Evaluation with an Application to the Population Pharmacokinetics of GliclazidePharmaceutical Research, 2006
- Comparison of four basic models of indirect pharmacodynamic responsesJournal of Pharmacokinetics and Biopharmaceutics, 1993
- A mathematical model of erythropoiesis in mice and rats Part 1: Structure of the modelCell Proliferation, 1989